Effects of Hydrogen Peroxide on Bovine Leukemia Virus Expression
-
A. Bondzio
Abstract
Several activators of bovine leukemia virus (BLV) expression, including lipopolysaccharides, phorbol esters and calcium ionophores, are known to generate reactive oxygen species (ROS). Therefore the influence of H2O2 on BLV expression in two BLV producing cell lines was investigated. The effect of H2O2 on BLV expression is apparently dose-dependent. Incubation of FLK/BLV cells with low concentrations of H2O2 (2.5 to 10 uM) induced a marked enhancement of BLV p24 synthesis and an activation of the long terminal repeat (LTR). Higher concentrations resulted in a decrease of proliferation, induction of apoptosis and in a decrease of BLV synthesis. Furthermore, in both cell lines H2O2 treatment led to the activation of NF-κB. Pretreatment of cells with antioxidants abrogated the H2O2-induced BLV expression. Taken together, our findings suggest that oxidative stress stimulates BLV expression via activation of NF-κB, raising the possibility that biological sources of H2O2, such as stimulated phagocytes, may influence BLV expression.
Copyright © 2003 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Protein Prenyltransferases: Anchor Size, Pseudogenes and Parasites
- Redox Regulation of Cell Growth and Cell Death
- Are Histones the Targets for Flavan-3-ols (Catechins) in Nuclei?
- Exploring the Role of 5’ Alternative Splicing and of the 3’-Untranslated Region of Cathepsin B mRNA
- Interaction of Maize Chromatin-Associated HMG Proteins with Mononucleosomes: Role of Core and Linker Histones
- Transcriptional Silencing of the TFPI-2 Gene by Promoter Hypermethylation in Choriocarcinoma Cells
- Solubilisation and Properties of the Sialate-4-O-Acetyltransferase from Guinea Pig Liver
- A Peroxidase from Lepista irina Cleaves β,β-Carotene to Flavor Compounds
- Physarum polycephalum Expresses a Dihydropteridine Reductase with Selectivity for Pterin Substrates with a 6-(1', 2-Dihydroxypropyl) Substitution
- Effects of Hydrogen Peroxide on Bovine Leukemia Virus Expression
- Ovarian Cancer Cell Proliferation and Motility Is Induced by Engagement of Integrin αvβ3/Vitronectin Interaction
- Novel Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems
- Inhibition of Intraperitoneal Tumor Growth of Human Ovarian Cancer Cells by Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems
- Expression of High Molecular Weight Cysteine Proteinase Inhibitor in Ovarian Cancer Tissues: Regulation of Cathepsin B Expression by Placental CPI
- Rapid Enzymatic Test for Phenotypic HIV Protease Drug Resistance
Articles in the same Issue
- Protein Prenyltransferases: Anchor Size, Pseudogenes and Parasites
- Redox Regulation of Cell Growth and Cell Death
- Are Histones the Targets for Flavan-3-ols (Catechins) in Nuclei?
- Exploring the Role of 5’ Alternative Splicing and of the 3’-Untranslated Region of Cathepsin B mRNA
- Interaction of Maize Chromatin-Associated HMG Proteins with Mononucleosomes: Role of Core and Linker Histones
- Transcriptional Silencing of the TFPI-2 Gene by Promoter Hypermethylation in Choriocarcinoma Cells
- Solubilisation and Properties of the Sialate-4-O-Acetyltransferase from Guinea Pig Liver
- A Peroxidase from Lepista irina Cleaves β,β-Carotene to Flavor Compounds
- Physarum polycephalum Expresses a Dihydropteridine Reductase with Selectivity for Pterin Substrates with a 6-(1', 2-Dihydroxypropyl) Substitution
- Effects of Hydrogen Peroxide on Bovine Leukemia Virus Expression
- Ovarian Cancer Cell Proliferation and Motility Is Induced by Engagement of Integrin αvβ3/Vitronectin Interaction
- Novel Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems
- Inhibition of Intraperitoneal Tumor Growth of Human Ovarian Cancer Cells by Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems
- Expression of High Molecular Weight Cysteine Proteinase Inhibitor in Ovarian Cancer Tissues: Regulation of Cathepsin B Expression by Placental CPI
- Rapid Enzymatic Test for Phenotypic HIV Protease Drug Resistance
